✦ LIBER ✦

Transforming Growth Factor-β in Cancer Therapy, Volume I || Topical Application of TGF-β1 Peptide Inhibitors for the Therapy of Skin Fibrosis

✍ Scribed by Jakowlew, Sonia B.

Book ID: 121454347
Publisher: Humana Press
Year: 2008
Tongue: English
Weight: 1009 KB
Category: Article
ISBN: 1597452920
DOI: 10.1007/978-1-59745-292-2_44

No coin nor oath required. For personal study only.

✦ Synopsis

Transforming Growth Factor- ß In Cancer Therapy, Vols. 1 And 2, Provides A Compendium Of Findings About The Role Of Transforming Growth Factor- ß (tgf- ß) In Cancer Treatment And Therapy. The First Volume, Basic And Clinical Biology, Is Divided Into Three Parts. This Volume’s Companion, Cancer Treatment In Therapy, Examines Transforming Growth Factor- ß In Other Developing And Advanced Cancers And Methods Of Treatment And Therapy.

📜 SIMILAR VOLUMES

Down-regulation of protein and mRNA expr

Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β1) type I and type II receptors in human prostate cancer

✍ Yanping Guo; Stephen C. Jacobs; Natasha Kyprianou 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 298 KB 👁 1 views

Transforming growth factor-b (TGF-b1) is a potent negative regulator of cell growth that transduces signals through interactions with type I and II receptors. Abnormal expression and mutational alterations of these receptors have been observed in several human malignancies. In this study, we investi

[Topics in Medicinal Chemistry] Cancer V

[Topics in Medicinal Chemistry] Cancer Volume 1 || Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor Receptor 2 for Cancer Therapy

✍ Bradbury, Robert H. 📂 Article 📅 2007 🏛 Springer Berlin Heidelberg ⚖ 503 KB

The effect of endocrine therapy on the l

The effect of endocrine therapy on the levels of oestrogen and progesterone receptor and transforming growth factor-β1 in metastatic human breast cancer: an immunocytochemical study

✍ Murray, P.A.; Gomm, J.; Ricketts, D.; Powles, T.; Coombes, R.C. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 668 KB

OL-004 Suppression of liver fibrosis is

OL-004 Suppression of liver fibrosis is associated with the decrease of transforming growth factor-β1 and increase of matrix metalloproteinase-1 expression after interferon-α therapy in chronic hepatitis C patients

✍ Yun-ru Li 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 149 KB

The role of Fas ligand and transforming

The role of Fas ligand and transforming growth factor β in tumor progression : Molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy

✍ Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Yoko Uchida; Tetsuya Toge 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

## Abstract Despite the fact that expression of Fas ligand (FasL) in cytotoxic T lymphocytes (CTLs) and in natural killer (NK) cells plays an important role in Fas‐mediated tumor killing, During tumor progression FasL‐expressing tumor cells are involved in __counterattacking__ to kill tumor‐infiltr